L92.2 Granuloma faciale [eosinophilic granuloma of skin]

Name of the Condition

• Granuloma faciale [eosinophilic granuloma of skin]

Summary

Granuloma faciale is a rare, benign skin condition characterized by the formation of well-circumscribed, reddish-brown or violaceous plaques, typically on the face. These lesions result from a localized inflammatory process involving eosinophils and other immune cells, leading to granuloma formation in the dermis. The condition is chronic and non-contagious, with lesions that may persist for months to years.

Causes

The exact cause of granuloma faciale is not fully understood, but it is thought to involve an immune-mediated reaction. Some cases may be associated with minor trauma, sun exposure, or underlying hematologic conditions, though no single trigger has been definitively identified. The condition is not linked to infection or malignancy.

Risk Factors

• Age: Most commonly affects middle-aged adults, though it can occur at any age.
• Gender: Slightly more prevalent in males.
• Sun exposure: Lesions often appear on sun-exposed areas of the face.
• Underlying conditions: Rarely associated with hematologic disorders, though the link is not well-established.

Symptoms

• Well-defined, firm plaques with a reddish-brown or violaceous hue.
• Lesions typically appear on the face, particularly the cheeks, nose, or forehead.
• Lesions are usually asymptomatic but may cause mild itching or tenderness.
• Lesions may persist for months to years without spontaneous resolution.

Diagnosis

Diagnosis typically involves a clinical examination and skin biopsy to identify the characteristic histologic findings of eosinophilic granulomatous inflammation. Laboratory tests, such as blood counts or imaging, may be performed to rule out associated conditions, but are not always necessary.

Treatment Options

• Topical or intralesional corticosteroids to reduce inflammation and improve appearance.
• Laser therapy (e.g., pulsed dye laser) to target vascular components and reduce redness.
• Surgical excision for persistent or cosmetically concerning lesions.
• Observation may be appropriate for asymptomatic cases.

Prognosis and Follow-Up

Granuloma faciale is a benign condition with no risk of progression to malignancy. Lesions may resolve spontaneously in some cases, but many persist or recur. Follow-up is recommended to monitor for changes in lesion appearance or symptoms, and to assess treatment response.

Complications

• Cosmetic concerns due to persistent or recurrent lesions.
• Rarely, secondary infection if lesions are scratched or traumatized.
• No systemic complications are associated with the condition.

Lifestyle & Prevention

• Sun protection (e.g., sunscreen, hats) may help reduce the risk of lesion development or exacerbation.
• Avoiding known triggers, such as minor trauma to the face, may be beneficial.
• Regular skin examinations to monitor for changes in lesion appearance.

When to Seek Professional Help

• If lesions are painful, rapidly growing, or associated with systemic symptoms (e.g., fever, fatigue).
• If lesions change in color, size, or texture, or if new lesions appear.
• If treatment options are desired for cosmetic or symptomatic relief.

Tips for Medical Coders

When coding for granuloma faciale, use the ICD-10-CM code L92.2. Documentation should include a description of the lesion's location, appearance, and any associated symptoms or treatments. Ensure the diagnosis is confirmed by clinical examination or biopsy to support accurate coding. Avoid using this code for other granulomatous skin conditions without clear differentiation.